Ahead of the High-Level Meeting on TB, Médecins Sans Frontières conducted a webinar on 8 September 2023 to provide information about the next phase of the Time for $5 Campaign, calling on the diagnostics company Cepheid and its parent corporation Danaher to reduce the price of the GeneXpert test cartridge to $5.

TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools.

New results show a much shorter treatment regimen for drug-resistant TB is superior to current options.

Médecins Sans Frontières releases the 6th edition of DR-TB Drugs Under the Microscope: 5 Urgent Actions to Improve DR-TB Treatment.

Tokyo, 15 March 2013 – Following Prime Minister Abe’s announcement today of Japan’s intention to join the Trans-Pacific Partnership (TPP) Agreement negotiations, international medical humanitarian organisation Médecins Sans Frontières (MSF) called on Japan and the rest of TPP negotiating countries to reject rules that threaten to dismantle internationally-agreed public health safeguards and restrict access to medicines in developing countries.

Few children at the paediatric tuberculosis hospital in Dushanbe look as active and healthy as Shirinmo. The little girl is bright and busy as she crawls across the waiting room floor. But get closer and you can hear that her breath comes in gasps and has a rattling sound. The devastating diagnosis: the nine-month-old is suffering from multidrug-resistant tuberculosis (MDR-TB), a disease that spreads easily and, if left untreated, kills.

Alarming new data suggest that the global scope of multidrug-resistant tuberculosis (MDR-TB) is much more vast than previously estimated, requiring a concerted international effort to combat this deadlier form of the disease, the medical humanitarian organization Médecins Sans Frontières (MSF) announced today.